Wednesday, 24 May 2017

Most Popular
Pharma News
BioTech News
MedTech News
BioServices News
Video Gallery

Inside Magazine

Drugs: Approved, and seeking approval

In 2016, the US Food and Drug Administration (FDA) approved 22 new drugs which was way lower than 2015 when 45 new drugs were launched. It was a year of disappointment for pharmaceutical companies and drug developers. However, the industry is optimistic that research on novel drugs has not slowed down and wheels of innovation is spinning ahead. BioSpectrum Asia takes a look at the drugs that are in phase III of clinical trial or have been recently approved. These drugs are indicated for life-
threatening diseases and once available in the market, they would be effective in battling the disease burden.

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls